share_log

Vivos Therapeutics | EFFECT: Others

Vivos Therapeutics | EFFECT: Others

Vivos Therapeutics | EFFECT:其他
美股sec公告 ·  08/08 06:11
Moomoo AI 已提取核心信息
Vivos Therapeutics, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of August 7, 2024, at 4:30 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This effectiveness indicates that Vivos Therapeutics has met the necessary regulatory requirements to move forward with its securities offerings.
Vivos Therapeutics, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of August 7, 2024, at 4:30 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This effectiveness indicates that Vivos Therapeutics has met the necessary regulatory requirements to move forward with its securities offerings.
vivos therapeutics公司是美国的一家上市公司,已经在2024年8月7日下午4:30与证券交易所(SEC)取得了重要的里程碑。 Form S-3 是一种注册表格,允许公司向潜在投资者提供更新的财务信息和证券发行。此有效性表示Vivos Therapeutics已经满足了前进证券发行的必要监管要求。
vivos therapeutics公司是美国的一家上市公司,已经在2024年8月7日下午4:30与证券交易所(SEC)取得了重要的里程碑。 Form S-3 是一种注册表格,允许公司向潜在投资者提供更新的财务信息和证券发行。此有效性表示Vivos Therapeutics已经满足了前进证券发行的必要监管要求。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息